Alza, Impax Clash Over Patents For ADD/ADHD Drug Concerta

Law360, New York (September 6, 2005, 12:00 AM EDT) -- California-based Alza Corporation, a maker of drugs for attention disorders, has filed a complaint against two domestic rivals over their attempts to gain approval for generic versions of its drug Concerta.

Alza alleges Impax Laboratories Inc. and Andrx Pharmaceuticals LLC infringe its patents by seeking to make generic versions of all doses of Concerta prior to the expiration of the patents in question.

Concerta, is made with active ingredient methylphenidate hydrochloride, a stimulant medication. It treats Attention Deficit Disorder (ADD) and attention deficit hyperactivity disorder (ADHD)....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.